Despite slightly lower than expected revenues for the half-year ending December 31, Adelaide company GroPep was on track for full recovery, said CFO Tony Mitchell today. [ + ]

Researchers hunting the serial murderer responsible for the progressive, mass-death of neurons in Alzheimer's disease, the most common form of dementia, have found a new suspect. [ + ]

The global oil and gas industry will benefit from the establishment of a world-class energy technology research alliance signed recently in Western Australia.

The first fruits of anti-cancer drug developer Peplin Biotech's landmark licensing deal with US pharmaceutical company Allergan have surfaced in the form of a 240 per cent surge in Peplin's first-half revenues. [ + ]

Biosensor company Ambri has learned first-hand the fickle nature of the share market -- a stock slide that saw the company lose almost a third of its value since mid-December, before recovering 22 per cent on Friday, was precipitated by a single shareholder selling off its entire holding in the company. [ + ]

Getting a suitably challenging position is a bigger concern to many returning expatriate Australians than salary, attendees heard at the first BioMelbourne Breakfast for this year. [ + ]

The story of the so-called prion diseases, including 'mad cow' disease, is one of the strangest in the annals of 20th century medical science -- and it grows stranger still. [ + ]

Melbourne diagnostics company Cellestis has received a major boost with the release of the US Centre for Disease Control and Prevention (CDC) guidelines for its Quantiferon-TB diagnostic test for tuberculosis (TB). [ + ]

A new branch of genetics is being born. It might legitimately be called junk science, but Prof John Mattick has dubbed it 'Rnomics'... and it's the stuff of revolution. [ + ]

Australian scientists are winners in the race to master new magnesium technology to build the motor vehicles and consumer goods of the future.

A collaboration between Adelaide company Bionomics and Johnson and Johnson Research (JJR) has been concluded without an ongoing commercial arrangement. [ + ]

Veteran Melbourne malaria researcher Prof Robin Anders believes a malaria vaccine is still at least eight to 15 years away -- but he is optimistic that a vaccine is feasible, and will be effective, despite the phenomenal capacity of the parasite, Plasmodium falciparum, to take evasive action against drugs and vaccines. [ + ]

UK-based Domantis, a developer of single-domain antibody therapeutics, has been granted a US patent on a new emulsion technique for selecting antibodies and antibody fragment. [ + ]

For most of us microwaves are a means to defrost frozen food or boil water, but research by telecommunications engineers at the University of Technology, Sydney is helping establish microwave energy as an important tool in treating potentially deadly heart rhythm disorders.

Perth-based probiotics and diagnostics company VRI BioMedical has named Dr Peter French as its new CEO. [ + ]